Nov 11, 2022 / 04:40PM GMT
Marc Frahm - Cowen Inc. - Analyst
All right. Welcome to the next session of the 6th Annual IO Next Summit, [here in Cowen. We are really] pleased to have for this session Taylor Schreiber, the CEO of Shattuck Labs, with us.
[I'd like to] remind everyone on the line that while I do have a list of questions to go through with Taylor, we'd love it to be interactive to the extent possible. So you can submit questions through the chat box on top of your screen as well as you can just e-mail me at [email protected], and I will try to pepper those questions in as we go through it.
So, Taylor, maybe just to start off to level set everybody, people who may not be super-familiar with Shattuck. If you can provide a summary of the ARC platform and kind of how it differs from traditional bispecifics in terms of the biology that it can address.
Taylor Schreiber - Shattuck Labs, Inc. - CEO & Co-founder
Sure. Hey, Marc, and thanks to both you, Marc, and Cowen for the invitation to participate today. So the ARC platform, ARC, first of all, stands for
Shattuck Labs Inc at Cowen IO Next Summit (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
